Ardelyx (ARDX) Capital Expenditures Growth (5y) (2018 - 2026)
Ardelyx (ARDX) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.40% |
| Dec 31, 2025 | 7.63% |
| Sep 30, 2025 | 26.06% |
| Mar 31, 2025 | 67.03% |
| Sep 30, 2024 | 3.74% |
| Jun 30, 2024 | 23.28% |
| Mar 31, 2024 | -1.89% |
| Dec 31, 2023 | -31.59% |
| Sep 30, 2023 | 52.54% |
| Mar 31, 2023 | -23.94% |
| Dec 31, 2022 | 15.15% |
| Dec 31, 2021 | 41.43% |
| Sep 30, 2021 | -22.71% |
| Jun 30, 2021 | 20.16% |
| Mar 31, 2021 | 31.22% |
| Dec 31, 2020 | -11.25% |
| Sep 30, 2020 | -55.68% |
| Mar 31, 2020 | -36.06% |
| Sep 30, 2019 | 5.31% |
| Jun 30, 2019 | -40.97% |